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A B S T R A C T
This is a protocol for a Cochrane Review (Overview). The objectives are as follows:
To produce an overview of Cochrane Reviews of non-pharmacological interventions with evidence relevant to community-based longer-
term stroke survivors or their carers, focusing on person-centred outcomes.
This will include:
• identifying types of non-pharmacological interventions that have been evaluated in the longer-term after stroke (included
intervention types), where such a trial has been included in a Cochrane Review;
• identify types of non-pharmacological intervention that may be applicable to the longer-term after stroke but have only been
evaluated in the shorter-term after stroke, where such a trial has been included in a Cochrane Review;
• categorise these intervention types according to the poststroke problems they are directly intended to address, as defined by
Cochrane Review authors;
• identifying the outcomes considered most important (primary outcomes) for included intervention types, as defined by
Cochrane Review authors;
• examining evidence of the effects of included intervention types specific to the longer-term after stroke;
• signposting readers to evidence of effective interventions;
• identifying opportunities for merging or splitting existing Cochrane Reviews.
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B A C K G R O U N D
Stroke is the second greatest cause of death and disability world-
wide after ischaemic heart disease (Feigin 2015; WHO 2018).
Annually, there are 10.3 million new strokes (Feigin 2017), with
around 795,000 people in the USA (Benjamin 2018), and more
than 100,000 people in the UK (Stroke Association 2018), ex-
periencing a stroke. The burden of stroke is particularly high in
low- and middle-income countries, where stroke incidence lev-
els now exceed those of high-income countries by approximately
29% (Feigin 2014; Thrift 2012). In high-income countries, im-
provements in care immediately following a stroke over recent
decades mean a greater proportion of people are surviving beyond
the first few months (henceforth ‘stroke survivors’) (Carter 2007;
Lee 2011). Globally, in 2013 there were 25.7 million stroke sur-
vivors alive (Feigin 2017). Almost two-thirds of UK stroke sur-
vivors leave hospital with a disability (Stroke Association 2018).
As such, stroke generates considerable health and social care costs.
In the UK, costs are estimated at GBP 8 billion a year, including
GBP 3 billion direct costs to the National Health Service, as well
as other wider economic costs such as informal care costs, benefits
payments, and lost economic productivity (National Audit Office
2010). Moreover, 30% of UK stroke survivors receive care infor-
mally from family and friends (henceforth ‘carers’) (Royal College
of Physicians 2018). Carers are thrust into a role that is often
physically, emotionally, and time intensive (Greenwood 2010; Ski
2015).
Description of life in the longer-term after
stroke
While there have been substantial improvements in the acute
stroke care pathway, longer-term outcomes remain poor for many
stroke survivors and their carers (Crichton 2016; Hawkins 2017;
Jaracz 2015; Meyer 2015; Murray 2007). In this review, we will
define ‘longer-term’ as six months or more after stroke. This time
point, while inevitably somewhat arbitrary, is beyond the current
scope of typical rehabilitation services, when people have had time
in the community livingwith their newcircumstances. The longer-
term after stroke follows the initial disruption to life, relationships,
and expectations experienced by many stroke survivors, and is a
period when stroke survivors may experience recovery, continuing
disruption, turbulent recovery and decline, or enduring decline
(Hawkins 2017). Similarly, while some carers of stroke survivors
adapt to successfully manage their new role, others experience bur-
den at varied times in the care trajectory up to at least five years
(Hung 2012; Greenwood 2009; Jaracz 2015; Quinn 2014; Tooth
2005; Visser-Meily 2008).
For many stroke survivors, longer-term outcome is poor; ap-
proximately one-third are left with some physical impairment
(Feigin 2010; McKevitt 2011), depression and fatigue are preva-
lent (Hackett 2014; van de Port 2006), inactivity common (Mayo
2002; Patel 2006), and quality of life often deteriorates (Kwok
2011). Many stroke survivors have comorbidities (94% in Scot-
land; Gallacher 2014), which needmanaging in addition to stroke
consequences. Data from the South London Stroke Register indi-
cated that 20% to 30% of stroke survivors have a poor outcome
over a range of domains up to 10 years after the incident event
(Wolfe 2011). Problems in the longer-term after stroke include the
physiological effects of the stroke as well as how those effects, the
event of the stroke, and the care received interact with the person,
their loved ones, and the wider social setting (Algurén 2012). For
example, a stroke may cause problems with motor control, cog-
nition, vision, energy, and speech and language functions, any of
which can make daily activities difficult (Sarre 2014). For another
stroke survivor, the shock of the stroke may cause a complete loss
of confidence, which makes their economic, social, and civic life
difficult (Peoples 2011; Salter 2008). For a family, loss of income,
changes in roles, the new support needs of the stroke survivor,
and changes in personality may place tremendous strain on the
individuals and the functioning of the family (Hesamzadeh 2015;
Sarre 2014).
Many stroke survivors require assistance from informal carers, of-
ten family members, for activities of daily living (Anderson 1995;
Guidetti 2010). This burden of care has an important effect on car-
ers’ physical and psychosocial wellbeing (Greenwood 2008; Parag
2008; Rigby 2009), with up to 48% of carers reporting health
problems and two-thirds a decline in social life (Murray 2003).
Carers also continue to have instrumental, informational, and
emotional needs in the longer term, for which they value support
from family members, healthcare professionals, friends, and peers
(Cameron 2013; Jaracz 2015).
Description of non-pharmacological
interventions for longer-term stroke survivors
or their carers
In the longer term, the care environment for stroke survivors
changes to one of living at home unassisted or assisted, or as a
resident of long-term care. These different circumstances provide
different opportunities and challenges to living that are likely to
result in different needs. They also provide different opportunities
and challenges to providing interventions.
We have not specified particular intervention types; however, for
pragmatic reasons of scale and based on our expertise, we have
limited our scope to non-pharmacological interventions following
an established approach for Cochrane Reviews (e.g. Legg 2011;
MacKay-Lyons 2013). We define ‘non-pharmacological’ to ex-
clude invasive interventions such as surgery or minimally invasive
interventions such as acupuncture, and to exclude pharmaceutical
substances and forms, but not advice about them as part of a larger
intervention.
Examples of broad groups of relevant interventions specifically
for stroke survivors include physical, cognitive, visual, speech and
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language training, and practice of daily activities. Relevant inter-
ventions that may be given to either stroke survivors or their car-
ers include provision of devices, information, advice, education,
lifestyle interventions, support for self-management, talking ther-
apies, and social and recreational activity. Interventions at the fam-
ily level may include social work, while interventions at the health
service level may include care co-ordination, care navigators, and
interdisciplinary management.
Because the problems people face in the longer-term after stroke
are so varied, interventions are likely to either be applicable only
to certain people, or to include a component of tailoring or cal-
ibration such as an assessment with protocolised responses, or a
discussion of needs with goal setting and action planning.
How the intervention might work
Because this overview will not be limited to specific interventions,
those includedmight work in a variety of ways. This is particularly
true given the broad range of effects a stroke can have. Overall,
interventions may seek to reverse the negative effects of the stroke,
to help people to accommodate their current circumstances suc-
cessfully, or both. They may also seek to prevent future problems
such as recurrent stroke. Interventions may, for example, be de-
signed to work by changing the person’s body functioning, their
knowledge, beliefs, or skills. They may seek to change thought
processes, emotions, intentions, goals, or behaviour. They may
seek to provide support to an individual (e.g. practical, emotional,
financial) or to identify or organise other sources of support.
Why it is important to do this overview
Despite policy recommendations for greater emphasis on longer-
term stroke care (Department of Health 2007; National Audit
Office 2010), and being a key component of theWorld StrokeOr-
ganization campaign, strategies for longer-term care are not well
developed. The provision of ineffective interventions has consid-
erable resource implications and potential to add to patient and
carer stress. As such, identifying the most effective interventions
to improve longer-term stroke outcomes is a recognised priority
for stroke research. In the UK, this was demonstrated during the
James Lind Alliance priority setting project, where “What are the
best ways to help people come to terms with the long-term conse-
quences of stroke?” was the second-highest priority research ques-
tion identified (Pollock 2012). This overview will help to address
this consumer priority.
This overview will examine the evidence for a wide range of in-
terventions for longer-term stroke survivors or their carers that
have been systematically reviewed by Cochrane. There is a sub-
stantial body of potentially relevant analyses to be synthesised,
which would be difficult for practitioners, policy makers, and con-
sumers to assimilate.Moreover, we plan to isolate the evidence that
applies specifically to the longer-term after stroke. This overview
will provide a comprehensive, accessible summary of the current
published evidence, as well as identify gaps for future research in
longer-term stroke care.
O B J E C T I V E S
To produce an overview of Cochrane Reviews of non-pharmaco-
logical interventions with evidence relevant to community-based
longer-term stroke survivors or their carers, focusing on person-
centred outcomes.
This will include:
• identifying types of non-pharmacological interventions that
have been evaluated in the longer-term after stroke (included
intervention types), where such a trial has been included in a
Cochrane Review;
• identify types of non-pharmacological intervention that
may be applicable to the longer-term after stroke but have only
been evaluated in the shorter-term after stroke, where such a trial
has been included in a Cochrane Review;
• categorise these intervention types according to the
poststroke problems they are directly intended to address, as
defined by Cochrane Review authors;
• identifying the outcomes considered most important
(primary outcomes) for included intervention types, as defined
by Cochrane Review authors;
• examining evidence of the effects of included intervention
types specific to the longer-term after stroke;
• signposting readers to evidence of effective interventions;
• identifying opportunities for merging or splitting existing
Cochrane Reviews.
M E T H O D S
This overview of Cochrane Reviews will include reviews that are
broadly relevant to community-based, longer-term stroke sur-
vivors or their carers, but only those comparisons with directly ap-
plicable evidence. We will reanalyse these comparisons using only
data from the relevant studies. Therefore, we will apply different
criteria at the level of the review and per comparison for included
reviews. The overview will delineate intervention types as they are
presented in the reviews and will not seek to reclassify these or
otherwise combine effect estimates from different reviews.
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Criteria for considering reviews for inclusion
For clarity, the following criteria will apply to reviews as a whole.
Types of reviews
• Current Cochrane Intervention reviews: the latest
published version of systematic reviews on the effects of
healthcare interventions produced by Cochrane review groups
that have not been withdrawn, without restriction by publication
date.
Types of interventions
Any of the interventions as grouped in the review meet the fol-
lowing criterion.
• Non-pharmaceutical and non-invasive (examples of
inclusions are dietary advice, exercise, self-management support,
transcutaneous electrical nerve stimulation; examples of
exclusions are medicines, nutritional supplements, surgery,
acupuncture).
Types of participants
At least one study included in the review has participants who
meet all of the following.
• Stroke survivors or their carers: at least 80% of
participants are stroke survivors or their carers, as defined in the
study. If the study includes people who have had a transient
ischaemic attack (TIA) in addition to people who have had a
stroke it will satisfy this criterion, but if the study only includes
people who have had a TIA it will not.
• At least six months after stroke: mean time since most
recent stroke (the participant’s or the person they care for) at the
start of intervention delivery is at least six months.
• Living in the community: more than 50% of participants
are not inpatients.
Criteria for considering comparisons for inclusion
The following criteria will apply to comparisons within reviews
that meet the criteria above.
Types of comparisons
• Intervention versus no additional intervention (e.g. usual
care) or placebo interventions (e.g. attention control
interventions) or
• comparisons of interventions which both meet the
inclusion criteria.
Where multiple time points are reported, we will select those clos-
est to intervention end and last available follow-up, where data
permit. Where a review conducts subgroup analyses but also re-
ports pooled totals across the subgroups, we will use the totals
across subgroups and ignore the subgrouping.
Types of interventions
All of the interventions in the comparison must be non-pharma-
ceutical and non-invasive.
Types of participants
At least one study in the comparison has participants who meet
all of the following.
• Stroke survivors or their carers: at least 80% of
participants are stroke survivors or their carers, as defined in the
study. If the study groups people who have had a stroke with
those who have had a TIA it will satisfy this criterion, but if the
study only includes people who have had a TIA it will not.
• At least six months after stroke: mean time since most
recent stroke (the participant’s or the person they care for) at the
start of intervention delivery is at least six months.
• Living in the community: more than 50% of participants
are not inpatients.
Types of outcomes
Because we will be using existing comparisons, the following are
inclusion criteria for comparisons rather than a schema for quan-
titative pooling of data.
Primary outcomes
We have selected primary outcomes with the aim of covering pa-
tient-relevant outcomes that may be relevant to a broad range of
stroke survivors and carers. In doing so, we have consulted with
our Consumer Research Advisory Group and drawn upon recent
prioritisation work (Davis 2017; Duncan Millar 2019), and a core
outcome set in aphasia (Wallace 2019), the only core outcome set
for effectiveness trials developed in conjunction with consumers
in the field of stroke that we are aware of.
Our primary outcomes for stroke survivors will include:
• quality of life: “individuals’ perception of their position in
life in the context of the culture and value systems in which they
live and in relation to their goals, expectations, standards and
concerns” (WHOQOL Group 1993; e.g. World Health
Organization Quality of Life assessment short-form
(WHOQOL-BREF)). We will not include subscales where an
instrument produces higher-order scales;
• self-perceived health status: self-perception of health
overall or dimensions thereof. Assessments typically incorporate
functioning, mood, and pain, for example Medical Outcomes
Study 36-item Short-Form health survey (SF-36), EuroQol 5-
Dimension health questionnaire (EQ-5D). We will not include
subscales where an instrument produces higher-order scales;
• emotional well-being: positive and negative emotional
states including pleasure, eudaimonia, depression, and anxiety,
for example Warwick-Edinburgh Mental Well-Being Scale
(WEMWBS), General Health Questionnaire (GHQ);
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• participation and extended activities of daily living:
involvement in society such as education, work, community life,
religion, politics, recreation/leisure, interpersonal interactions,
and other complex tasks/activities required to live in the
community, for example London Handicap Scale (LHS),
Reintegration to Normal Living Index (RNLI), Nottingham
Extended Activities of Daily Living Scale (NEADL).
For carers, the same outcomes are of interest, with the addition of:
• carer strain and related concepts: such as burden or
coping, for example Caregiver Burden Scale.
Secondary outcomes
Secondary outcomes will be the primary outcomes of included
reviews, excluding body functioning and structure (impairment)
outcomes. We will group outcomes according to the International
Classification of Functioning, Disability and Health (ICF; WHO
2001), or other frameworks if the ICF is not applicable. This ap-
proach to secondary outcomes uses the expertise of review authors
to capture specific outcomes of relevance, given the variety of se-
quelae of stroke. We have chosen to exclude body functioning
and structure outcomes in consultation with our consumer group,
to make the review more manageable, as these can be considered
mediators of patient-relevant outcomes and are likely to be rele-
vant only to particular interventions. Similarly, we will not specify
particular adverse events, but will summarise which (if any) are
considered by each review and their findings.
Search methods for identification of reviews
We will handsearch the complete list of reviews and protocols
prepared by the Cochrane Stroke Group (CSG). In addition, we
will search the Cochrane Database of Systematic Reviews (CDSR)
using a search strategy that the CSG Information Specialist has
helped us to develop (see Appendix 1).
Data collection and analysis
We will use Covidence software for data management throughout
the process of selecting reviews and extracting data. Should this
prove to be infeasible, we will develop an inhouse database for this
purpose.
Selection of reviews
Twooverview authorswill independently screen titles and abstracts
of records identified from the electronic searches and retain any
that are potentially relevant. We will obtain the full-text of those
reviews and, where necessary to assess the time since most recent
stroke, their included studies. We will include the reviews that
meet our criteria. We will retain protocols that appear likely to
meet the criteria as ongoing reviews. Where inclusion is unclear,
the overview authors will discuss the issues at a consensus meeting.
Selection of non-pharmacological interventions trialled in
stroke but not longer-term stroke
To address our second objective, during the review selection pro-
cess we will identify current Cochrane intervention reviews that
meet our intervention criteria and the first of our participant crite-
ria (a study where at least 80% are stroke survivors or their carers).
Reviews which we later exclude because the other participant cri-
teria are not met (i.e. living in the community at least six months
after stroke) will form our selection of non-pharmacological in-
terventions trialled in stroke but not longer-term stroke.
Selection of reviews where several reviews assess the same
intervention
Because we are only including Cochrane Reviews, we do not an-
ticipate identifying reviews that address identical topics. However,
we may identify several reviews assessing the same intervention.
Where several reviews assess the same intervention with regard to
different outcomes, or different types of poststroke problems, we
will retain each review. Where several reviews assess the same in-
tervention in different populations that each include a poststroke
population (e.g. stroke survivors, people with acquired brain in-
jury, adults), we will select the review with the most participants
in studies that meet our criteria and exclude the others. Where no
one review can be selected through this method, we will select the
review that has the most similar inclusion criteria to our popula-
tions of interest.
Selection of comparisons
Wewill examine the comparisons reported in the included reviews
and include those that meet our criteria. Where inclusion is un-
clear, the overview authors will discuss that comparison at a con-
sensus meeting.
Data extraction and management
Two overview authors will extract data independently using a form
that has been specifically designed and piloted by the overview
author team. The overview authors will discuss any disagreements
that arise at a consensus meeting.
Data extracted will include the following.
Review
• Aims and rationale.
• Types of studies.
• Types of participants and how defined.
• Interventions.
• Outcomes assessed and those that were primary.
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• Adverse events.
• Date of last search.
• Method of assessing quality of studies.
• Number of included studies and their references.
• Number of included participants.
Studies included in reviews
• References.
• Whether the study meets the inclusion criteria (participant).
For studies which meet the inclusion criteria
• Types of participants (stroke survivors or carers, or both,
and how defined).
• Time since most recent stroke of participants at start of
intervention.
• Risk of bias as assessed by the authors of the included
review.
Comparisons/analyses
We will download forest plot data from the CDSR for included
reviews. In addition, wewill extract the following for each included
comparison.
• Compared conditions (e.g. intervention type versus usual
care).
• Outcome that it maps to in our scheme and details of the
measures used.
• Specifics of time points, if any (e.g. end of intervention).
• Specifics of participants, if only a subset of those included
in the review are specified (e.g. outpatients only).
• GRADE rating, including reasons.
We will contact the authors of included reviews to confirm or
obtain data if we are uncertain about the reported data or when
relevant data are mentioned but not reported. If the review is more
than two years old or if the date that the next stage was expected
has expired, we will contact authors to ask about the status of any
update.
Assessment of methodological quality of included
reviews
We will assess the methodological quality of individual reviews
using AMSTAR 2 (Shea 2017). Two overview authors will inde-
pendently conduct ratings, in duplicate, on piloted forms. The
overview authors will resolve disagreements by consensus. We will
present judgements per item with a supporting statement and will
rate overall confidence in the results of the review in line with the
advice of the AMSTAR 2 authors (Shea 2017).
Assessment of methodological quality of individual
studies
Wewill report Cochrane ‘Risk of bias’ assessments where theywere
conducted by the original Cochrane review authors. We will not
reassess risk of bias.
Assessment of overlap
We will include overlapping reviews (where primary studies are
included inmultiple reviews) as wewill not pool effect estimates of
reviews. To assess the overlap between reviews with respect to the
studies they included, we will present a citation matrix, calculate
the corrected covered area (CCA) and interpret it as slight (0 to
5), moderate (6 to 10), high (11 to 15) or very high (greater than
15) overlap as recommended by Pieper 2014. Additionally, we will
conduct a network analysis with reviews linked to the studies that
they include in a directed network. We will use visual inspection
based on a Force Atlas layout (Gephi 2017), and a cluster analysis
using the Girvan-Newman method (Girvan 2002), to identify
‘communities’ of reviews and studies.
Data synthesis
Wewill reanalyse included comparisons using only studiesmeeting
the participant criteria. We will conduct a narrative synthesis of
these results and the results from the included reviews for thewhole
population, grouped by outcomes, the problems addressed, and
the interventions evaluated.
Assessment of quality of evidence
We will use GRADE to rate the quality of evidence for each re-
analysed comparison based on the methods described in Chapter
11 of the Cochrane Handbook for Systematic Reviews of Interven-
tions, using GRADEprofiler (GRADEproGDT) software (Guyatt
2011; Schünemann 2017), and then for each intervention-out-
come (i.e. across comparisons addressing the same outcome type
for the same intervention type). Two overview authors will inde-
pendently conduct ratings in duplicate. The overview authors will
resolve disagreements by consensus. In the narrative synthesis, we
will present detailed results formoderate- or high-quality evidence;
where evidence is low quality, very low quality, or unavailable this
will be summarised. We will present a summary of quality and
direction of evidence in a table following a similar style to that of
Pollock 2014 (a mock-up example is presented in Figure 1).
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Figure 1. Example of table summarising quality and direction of evidence of intervention effects for
particular problems.
We will prepare a ‘Summary of findings’ table for each included
intervention type to present the results of meta-analysis and narra-
tive synthesis for the comparisons with no additional intervention
or placebo interventions. We will present results from the end of
the intervention for each of this overview’s primary outcomes, in-
cluding potential harms, as well as the primary outcome(s) of the
Cochrane Review for that intervention (the source of the compar-
ison), which are included in this overview as secondary outcomes,
as outlined in the ‘Types of outcomes section.
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A P P E N D I C E S
Appendix 1. Cochrane Library search strategy
1. MeSH descriptor: [Cerebrovascular Disorders] this term only
2. MeSH descriptor: [Basal Ganglia Cerebrovascular Disease] this term only
3. MeSH descriptor: [Brain Ischemia] explode all trees
4. MeSH descriptor: [Carotid Artery Diseases] explode all trees
5. MeSH descriptor: [Cerebral Small Vessel Diseases] explode all trees
6. MeSH descriptor: [Intracranial Arterial Diseases] explode all trees
7. MeSH descriptor: [Intracranial Embolism and Thrombosis] explode all trees
8. MeSH descriptor: [Intracranial Hemorrhages] explode all trees
9. MeSH descriptor: [Stroke] explode all trees
10. MeSH descriptor: [Vasospasm, Intracranial] this term only
11. MeSH descriptor: [Vertebral Artery Dissection] this term only
12. (*stroke* or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH):ti,ab,kw (Word variations have been
searched)
13. ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying)
near/5 (isch?emi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)):ti,ab,kw (Word variations have been searched)
14. ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid) near/5 (h?
emorrhag* or h?ematoma* or bleed*)):ti,ab,kw (Word variations have been searched)
15. MeSH descriptor: [Brain Injuries] this term only
16. MeSH descriptor: [Brain Injury, Chronic] this term only
17. MeSH descriptor: [Brain Damage, Chronic] this term only
18. (acquired near/5 brain injur*):ti,ab,kw (Word variations have been searched)
19. {or #1-#18} in Cochrane Reviews, Cochrane Protocols
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